FLAM
LABD icon

First Light Asset Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

First Light Asset Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,028
Closed -$2.3M – 39
2025
Q1 		$2.3M Buy
+14,028
New +$1.03M 0.26% 36
2020
Q2 		– Sell
-77
Closed -$217K – 65
2020
Q1 		$217K Buy
+77
New +$220K 0.04% 62

Other funds holding LABD

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

First Light Asset Management's LABD Position: Q2 2025 in Review

First Light Asset Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2025, closing a stake of 14,028 shares — an estimated $2.3M sold.

First Light Asset Management first reported a position in LABD in Q1 2020 and held it in 2 quarters. The position peaked at $2.3M in Q1 2025. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2025.

  • First Light Asset Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2025 after selling out during the quarter.
  • First Light Asset Management sold 14,028 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2025, an estimated $2.3M.
  • First Light Asset Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2020 and held it in 2 quarters.
  • First Light Asset Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $2.3M in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2025.

Based on First Light Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.